Hospital Pharmacy, RWTH Aachen University Hospital, Steinbergweg 20, 52074, Aachen, Germany.
Section of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Department of Pediatric and Adolescent Medicine, RWTH Aachen University Hospital, Aachen, Germany.
Paediatr Drugs. 2021 May;23(3):223-240. doi: 10.1007/s40272-021-00450-6. Epub 2021 May 7.
Pediatric medication therapy is prone to errors due to the need for pharmacokinetic and pharmacodynamic individualization and the diverse settings in which pediatric patients are treated. Prescribing errors have been reported as the most common medication error.
The aim of this review was to systematically identify interventions to reduce prescribing errors and corresponding patient harm in pediatric healthcare settings and to evaluate their impact.
Four databases were systematically screened (time range November 2011 to December 2019), and experimental studies were included. Interventions to reduce prescribing errors were extracted and classified according to a 'hierarchy of controls' model.
Forty-five studies were included, and 70 individual interventions were identified. A bundle of interventions was more likely to reduce prescribing errors than a single intervention. Interventions classified as 'substitution or engineering controls' were more likely to reduce errors in comparison with 'administrative controls', as is expected from the hierarchy of controls model. Fourteen interventions were classified as substitution or engineering controls, including computerized physician order entry (CPOE) and clinical decision support (CDS) systems. Administrative controls, including education, expert consultations, and guidelines, were more commonly identified than higher level controls, although they may be less likely to reduce errors. Of the administrative controls, expert consultations were most likely to reduce errors.
Interventions to reduce pediatric prescribing errors are more likely to be successful when implemented as part of a bundle of interventions. Interventions including CPOE and CDS that substitute risks or provide engineering controls should be prioritized and implemented with appropriate administrative controls including expert consultation.
儿科药物治疗由于需要进行药代动力学和药效学个体化以及儿科患者治疗环境多样化,容易出现错误。据报道,处方错误是最常见的用药错误。
本综述旨在系统地确定减少儿科医疗保健环境中处方错误和相应患者伤害的干预措施,并评估其影响。
系统筛选了四个数据库(时间范围为 2011 年 11 月至 2019 年 12 月),并纳入了实验研究。提取并根据“控制层次”模型对减少处方错误的干预措施进行分类。
共纳入 45 项研究,确定了 70 项单独的干预措施。与单一干预相比,一揽子干预措施更有可能减少处方错误。与“行政控制”相比,分类为“替代或工程控制”的干预措施更有可能减少错误,这符合控制层次模型的预期。有 14 项干预措施被归类为替代或工程控制,包括计算机化医嘱录入 (CPOE) 和临床决策支持 (CDS) 系统。行政控制,包括教育、专家咨询和指南,比更高层次的控制更常见,但它们可能不太可能减少错误。在行政控制中,专家咨询最有可能减少错误。
作为一揽子干预措施的一部分实施减少儿科处方错误的干预措施更有可能成功。应优先考虑并实施包括 CPOE 和 CDS 在内的替代风险或提供工程控制的干预措施,并结合适当的行政控制,包括专家咨询。